Investments, M&A & Funding

The deal builds on Novonesis’ original 2013 investment in MicroBioGen and its current 23% stake in the Sydney-based firm, extending a collaboration between the two companies that spans more than a decade.

The two developments form part of Döhler’s broader growth strategy, aimed at bringing production, technical expertise and customer support closer to key food, beverage and life science and nutrition markets.

The capital will facilitate a Final Investment Decision for Phytokana’s proposed dry fractionation plant located in Strathmore, which is designed to process an estimated 30,000 metric tonnes each year.

The new line has been installed at the company’s Weston Road site in Crewe, increasing its overall cookie production capacity by more than 30%.

The company plans to invest around €500m (US$576.3m) across the sites in Belgium, the US and Thailand by 2030.